美國居民不適用 XM 服務。

B
B

BayerAG

財經新聞

Reuters - 4天前

Water finance pipe is full of recycled pledges

BREAKINGVIEWS-Water finance pipe is full of recycled pledges The author is a Reuters Breakingviews columnist. The opinions expressed are his own. Refiles to change dateline. By Antony Currie NEW YORK, March 28 (Reuters Breakingviews) - Few enjoy being packed like sardines in a windowless conference room in the bowels of the United Nations. But for the financially-straitened water industry, the prospect of being inundated with cash was more than enough.
A
A
B
V
A
C
S
X
Reuters - 1週前

Bayer's pharma chief hopes EU takes time to improve drug rules reform

UPDATE 1-Bayer's pharma chief hopes EU takes time to improve drug rules reform Shorter drug exclusivity 'catastrophic' -Bayer executive Oelrich Oelrich says U.S. market more attractive than Europe Warns that IRA rules could lead to fewer drug use cases Adds comment on new U.S. drug pricing rules By Ludwig Burger and Patricia Weiss FRANKFURT, March 24 (Reuters) - The European Union's decision to postpone rule changes for the pharmaceutical industry could open the way for a rethink of a decision t
B
Reuters - 1週前

Bayer exec says he hopes EU takes time to improve drug rules reform

Bayer exec says he hopes EU takes time to improve drug rules reform By Ludwig Burger and Patricia Weiss FRANKFURT, March 24 (Reuters) - The head of Bayer's BAYGn.DE pharmaceuticals unit said he hopes a recent European Union decision to postpone rule changes for the pharmaceutical industry means that a cut in intellectual drug property protection will be reconsidered.
B
Reuters - 1週前

Bayer says drug research focus no longer on women's health

UPDATE 1-Bayer says drug research focus no longer on women's health adds detail By Ludwig Burger and Patricia Weiss FRANKFURT, March 24 (Reuters) - Bayer BAYGn.DE said the focus of its drug research would shift away from women's health, a traditional pillar of Germany's largest drugmaker, to hone in on neurology, rare diseases and immunology. "When it comes to research and the subsequent clinical phases, we will no longer have an explicit focus on women's health," the head of Bayer's pharmaceuti
B
Reuters - 1週前

Bayer says drug research focus no longer on women's health

Bayer says drug research focus no longer on women's health By Ludwig Burger and Patricia Weiss FRANKFURT, March 24 (Reuters) - Bayer BAYGn.DE said the focus of its drug research would shift away from women's health, a traditional pillar of Germany's largest drugmaker, to hone in on neurology, rare diseases and immunology. "When it comes to research and the subsequent clinical phases, we will no longer have an explicit focus on women's health," the head of Bayer's pharmaceuticals unit, Stefan Oel
B

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示：您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明。